◀ Back to VEGFA

NPPC — VEGFA

Text-mined interactions from Literome

Casserly et al., Life Sci 2011 (Anoxia...) : C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade
Pedram et al., J Biol Chem 1997 : Atrial natriuretic peptide (ANP), C-type natriuretic peptide , and C-ANP- ( 4-23 ), a ligand for the natriuretic peptide clearance receptor, equipotently inhibited production of VEGF by as much as 88 % and inhibited ET- or hypoxia stimulated VEGF transcription